Jose Manuel Otero's most recent trade in Lexeo Therapeutics Inc. was a trade of 5,930 Common Stock done at an average price of $2.6 . Disclosure was reported to the exchange on March 13, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexeo Therapeutics Inc | Jose Manuel Otero | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 2.64 per share. | 13 Mar 2026 | 5,930 | 131,390 | - | 2.6 | 15,679 | Common Stock |
| Lexeo Therapeutics Inc | Jose Manuel Otero | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.40 per share. | 18 Feb 2026 | 3,016 | 125,460 | - | 6.4 | 19,294 | Common Stock |
| Lexeo Therapeutics Inc | Jose Manuel Otero | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 260,000 | 260,000 | - | - | Stock Option (right to buy) | |
| Lexeo Therapeutics Inc | Jose Manuel Otero | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 65,000 | 128,476 | - | 0 | Common Stock | |
| Lexeo Therapeutics Inc | Jose Manuel Otero | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 9.27 per share. | 18 Nov 2025 | 721 | 63,476 | - | 9.3 | 6,684 | Common Stock |
| Lexeo Therapeutics Inc | Jose Manuel Otero | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 9.27 per share. | 18 Nov 2025 | 721 | 63,476 | - | 9.3 | 6,684 | Common Stock |
| Lexeo Therapeutics Inc | Jose Manuel Otero | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 5,940 | 66,312 | - | 0 | Common Stock | |
| Lexeo Therapeutics Inc | Jose Manuel Otero | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 8.93 per share. | 15 Oct 2025 | 2,091 | 64,221 | - | 8.9 | 18,683 | Common Stock |
| Lexeo Therapeutics Inc | Jose Manuel Otero | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 9.54 per share. | 15 Oct 2025 | 24 | 64,197 | - | 9.5 | 229 | Common Stock |
| Lexeo Therapeutics Inc | Jose Manuel Otero | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 4.67 per share. | 18 Aug 2025 | 2,848 | 60,372 | - | 4.7 | 13,294 | Common Stock |
| Lexeo Therapeutics Inc | Jose Manuel Otero | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 2.61 per share. | 14 Mar 2025 | 5,720 | 63,220 | - | 2.6 | 14,929 | Common Stock |
| Lexeo Therapeutics Inc | Jose Manuel Otero | Chief Technical Officer | 12 Jun 2024 | 187,500 | 187,500 | - | - | Stock Option (Right to Buy) | ||
| Lexeo Therapeutics Inc | Jose Manuel Otero | Chief Technical Officer | 12 Jun 2024 | 31,250 | 31,250 | - | 0 | Common Stock |